Glioblastoma

Rather than trying to develop even stronger chemotherapy drugs, our approach aims to make cancer cells more sensitive to existing treatments by blocking their defence mechanisms. In this case, blocking TLK1 protein’s activity weakens the ability of cancer cells to survive, making it easier to kill them